A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients

J Neurovirol. 1999 Oct;5(5):529-32. doi: 10.3109/13550289909045382.

Abstract

In the possible role for human herpesviruses (HHV) in the pathogenesis of multiple sclerosis (MS) neither clear distinction between the two variants of HHV-6, nor the involvement of HHV-7 have been described. Therefore, we quantitated HHV-6 variant specific and HHV-7 reacting antibodies in the CSF of 13 patients with MS or other neurological disorders by ELISA. Predominance in the positivity of IgG (67%) and IgM (44%) to HHV-6B over that of IgG (44%) with no detectable IgM to HHV-6A, and no antibodies to HHV-7 were found in the CSF of MS patients. None of these antibodies were found in the CSF of controls. This suggests that, intrathecal chronic active or primary HHV-6B infection might contribute to MS progression, while the local effects of HHV-6A and HHV-7 seem to be less important.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Herpesvirus 6, Human / immunology*
  • Herpesvirus 7, Human / immunology*
  • Humans
  • Immunoglobulin G / cerebrospinal fluid
  • Immunoglobulin M / cerebrospinal fluid
  • Male
  • Middle Aged
  • Multiple Sclerosis / cerebrospinal fluid
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / virology*
  • Pilot Projects

Substances

  • Immunoglobulin G
  • Immunoglobulin M